Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Naringin Potential treatment - theoretical effect Natural product Antiviral Jan/06/2021 4 0
Quercetin Potential treatment - theoretical effect Natural product Antiviral Jan/06/2021 9 0
Convalescent plasma Emergency use authorization Experimental Antiviral Jan/06/2021 26 5
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jan/05/2021 73 13
Myricetin Potential treatment - theoretical effect Natural product Antiviral Dec/28/2020 4 0
Hypericin Potential treatment - theoretical effect Natural product Antiviral Dec/08/2020 5 0
Rutin Potential treatment - pre-clinical evidence Natural product Antiviral Dec/08/2020 5 0
Azithromycin Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/04/2020 17 6
Theaflavin 3,3'-digallate Potential treatment - theoretical effect Natural product Antiviral Nov/23/2020 2 0
Shikonin Potential treatment - pre-clinical evidence Natural product Antiviral Oct/29/2020 2 1